Tanzeum

Indicated For

Type 2 diabetes mellitus

About This Medication

# Important Notice: Tanzeum (Albiglutide) is No Longer Available Unfortunately, we cannot provide a patient assistance program guide for Tanzeum (albiglutide) because this medication is no longer available in the United States. ## What Happened to Tanzeum? GlaxoSmithKline (GSK) discontinued Tanzeum (albiglutide) in May 2018.[8] The company made the initial discontinuation announcement in August 2017, citing limited prescribing of the drug and not safety concerns.[8] The medication was removed from the market due to low demand, not because of any problems with its safety or effectiveness. ## About Tanzeum Tanzeum was a once-weekly injectable medication approved by the FDA in April 2014 for treating type 2 diabetes.[7] It belonged to a class of drugs called GLP-1 receptor agonists, which work by helping the body reduce blood glucose levels.[6] Patients administered Tanzeum once weekly via subcutaneous injection in the abdomen, thigh, or upper arm using an injection pen.[7] ## If You Were Taking Tanzeum If you are currently taking Tanzeum or were previously prescribed this medication, your healthcare provider should have transitioned you to an alternative GLP-1 receptor agonist therapy before the product was discontinued.[8] Contact your doctor to discuss other available treatment options for managing your type 2 diabetes. ## GSK Patient Assistance Programs for Other Medications While Tanzeum is no longer available, GSK continues to offer patient assistance programs for other prescription medicines and vaccines.[1] If you are prescribed a different GSK medication and need financial assistance, you may be eligible for help. ### GSK Patient Assistance Program Overview GSK's Patient Assistance Programs provide certain GSK prescription medicines and vaccines at no cost to eligible patients.[1] These programs are managed by the GSK Patient Access Programs Foundation, an independent 501(c)(3) charitable foundation that operates separately from GSK.[1] ### Eligibility Requirements To qualify for GSK's Patient Assistance Program for prescription medicines, you typically must meet these criteria:[2] - Meet financial income eligibility criteria - Be uninsured OR have Medicare and meet other program requirements - Live in the United States, Puerto Rico, or the US Virgin Islands (for certain specialty and oncology medicines) - Be treated by a US Licensed Healthcare Provider ### How to Apply To learn about assistance for a specific GSK prescription medicine, visit the GSK Patient Assistance Program website or call 1-866-728-4368 to request a refill or learn more about eligibility.[2] ### Additional Support Options GSK also offers other support programs beyond patient assistance: - **Together with GSK**: This program provides coverage support, cost support, and patient journey support, including guidance on insurance coverage and identification of payment options for eligible patients.[9] - **GSK Reimbursement Resource Center**: This program helps patients and healthcare professionals with coverage, coding, and reimbursement issues for certain GSK products.[5] ## Important Disclaimer This information is provided for educational purposes only. Patient assistance programs do not constitute health insurance, and availability varies for each patient and GSK product. Program terms and conditions are subject to change. Always consult with your healthcare provider about your treatment options and financial assistance programs. For the most current information about GSK assistance programs, visit GSKForYou.com or call 1-866-728-4368.

Program information last verified: March 30, 2026